BTT-105

N/A

Report date: 2022/02/28 17:27:42

NME

Base Information

Drug NameBTT-105

Drug Alias NameBTT-105

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLipid peroxidation inhibitorsNuclear factor erythroid 2-related factor 2 stimulantsNitric oxide synthase stimulants

TargetsNuclear factor erythroid 2-related factor 2Nitric oxide synthase

Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiotoxtech Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

ATC CodeN/A